𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab

✍ Scribed by Robert D. Mass; Michael F. Press; Steven Anderson; Melody A. Cobleigh; Charles L. Vogel; Noël Dybdal; Grazyna Leiberman; Dennis J. Slamon

Book ID
115075675
Publisher
CIG Media Group, LP.
Year
2005
Tongue
English
Weight
496 KB
Volume
6
Category
Article
ISSN
1526-8209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative HER2 protein levels predict
Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab
✍ Allan Lipton; Wolfgang J. Köstler; Kim Leitzel; Suhail M. Ali; Jeff Sperinde; Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

## Abstract ## BACKGROUND: Only a portion of breast cancer patients currently selected for trastuzumab therapy respond. ## METHODS: Using a novel assay (HERmark) to quantify total human epidermal growth factor receptor 2 (HER2) expression, the authors examined outcomes in 102 trastuzumab‐treated